The FDAs Zepbound approval announcement also notes that higher-dose tirzepatide produced significant average weight reduction in clinical trials
If you experience dizziness, severe nausea, weakness, or symptoms of low blood sugar, stop fasting and contact your healthcare provider promptly
Aim to include 12 servings of these proteins in each meal to hit the recommended 0.81.2 g of protein per pound of body weight

Final Verdict: 7 Clinical Facts Ozempic is not licensed for weight loss in the UK Wegovy is the licensed semaglutide weight management product Mounjaro and Wegovy are different drugs tirzepatide (dual GLP-1/GIP) vs semaglutide (GLP-1 only) In the SURMOUNT-5 head-to-head trial, Mounjaro produced 20.2% vs Wegovys 13.7% average weight loss Wegovy is approximately 75/month cheaper at Slinic maintenance doses important for cost-sensitive patients Wegovy has the NICE cardiovascular indication (April 2026) Mounjaro does not yet have this label Wegovy now has a licensed oral version (MHRA June 2026) Mounjaro does not yet have an oral equivalent Neither Ozempic off-label nor compounded alternatives are appropriate when licensed products are readily available from a GPhC-registered UK pharmacy Slinic prescribes Mounjaro and Wegovy both correctly licensed, both from Eli Lilly and Novo Nordisk authorised supply chains, both reviewed by a registered UK prescriber

Poor dietary intake of B12-rich foods, such as meat, fish, and dairy products, is one of the most common causes of vitamin B12 deficiency